Chemoradiotherapy for anal cancer: are we as good as we think? D. MartinC. RödelE. Fokas Review Article 01 April 2019 Pages: 369 - 373
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer Anastassia LöserBurkhard BeyerRudolf Schwarz Original Article 02 November 2018 Pages: 374 - 382
Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy Ahmed GawishAhmed Ali ChughtaiMichael J Eble Original Article 17 October 2018 Pages: 383 - 392
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial Elke RammantPiet OstValérie Fonteyne Original Article 07 November 2018 Pages: 393 - 401
Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer M. DanielP. KuessP. Baltzer Original Article Open access 26 November 2018 Pages: 402 - 411
Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study Katsumasa NakamuraSaiji OhgaHidetoshi Yamanaka Original Article 05 December 2018 Pages: 412 - 419
Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer Daniel WalacidesAstrid MeierChristoph Henkenberens Original Article 04 January 2019 Pages: 420 - 429
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy Nina PoetschAlina SturdzaVeronika Seebacher Original Article Open access 08 February 2019 Pages: 430 - 440
A fatal case of Fournier’s gangrene during neoadjuvant radiotherapy for rectal cancer Rainer Johannes KlementGabriele SchäferReinhart A. Sweeney Case Study 23 November 2018 Pages: 441 - 446
Beim HPV-assoziierten Oropharynxkarzinom ist die Radiochemotherapie mit Cisplatin der Bioradiotherapie mit Cetuximab in Bezug auf das Gesamtüberleben überlegen Sabine Semrau Literatur kommentiert 21 February 2019 Pages: 447 - 449
Endokrine Funktionsstörungen nach Bestrahlung von Hirntumoren bei Kindern und jungen Erwachsenen Sophia ScharlStephanie E. Combs Literatur kommentiert 26 February 2019 Pages: 450 - 452
Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom Julia SchmidtSteffen AppoldEsther G. C. Troost Literatur kommentiert 21 February 2019 Pages: 453 - 456